Jpmorgan Chase & CO Liquidia Corp Transaction History

Jpmorgan Chase & CO

$1.27 Trillion
Q1 2025

A detailed history of Jpmorgan Chase & CO transactions in Liquidia Corp stock. As of the latest transaction made, Jpmorgan Chase & CO holds 62,523 shares of LQDA stock, worth $1.48 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

62,523

Previous 28,205 121.67%

Holding current value

$1.48 Million

Previous $331,000 178.55%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 12, 2025	BUY	$11.36 - $16.5 $389,852 - $566,247	34,318 Added 121.67%	62,523 $922,000
Q4 2024 Feb 12, 2025	SELL	$9.82 - $11.8 $2.03 Million - $2.44 Million	-207,188 Reduced 88.02%	28,205 $331,000
Q3 2024 Dec 26, 2024	BUY	$8.9 - $14.11 $1.88 Million - $2.97 Million	210,753 Added 855.33%	235,393 $2.35 Million
Q3 2024 Nov 08, 2024	BUY	$8.9 - $14.11 $1.88 Million - $2.97 Million	210,753 Added 855.33%	235,393 $2.35 Million
Q2 2024 Dec 26, 2024	SELL	$11.96 - $15.71 $2.52 Million - $3.31 Million	-210,753 Reduced 89.53%	24,640 $295,000
Q2 2024 Aug 12, 2024	BUY	$11.96 - $15.71 $60,386 - $79,319	5,049 Added 25.77%	24,640 $295,000
Q1 2024 Dec 26, 2024	SELL	$11.35 - $16.73 $2.45 Million - $3.61 Million	-215,802 Reduced 91.68%	19,591 $288,000
Q1 2024 May 10, 2024	SELL	$11.35 - $16.73 $134,054 - $197,598	-11,811 Reduced 37.61%	19,591 $288,000
Q4 2023 Dec 26, 2024	SELL	$5.77 - $12.19 $1.18 Million - $2.49 Million	-203,991 Reduced 86.66%	31,402 $377,000
Q4 2023 Feb 12, 2024	SELL	$5.77 - $12.19 $4,679 - $9,886	-811 Reduced 2.52%	31,402 $377,000
Q3 2023 Nov 14, 2023	SELL	$6.27 - $8.15 $28,779 - $37,408	-4,590 Reduced 12.47%	32,213 $204,000
Q2 2023 Aug 11, 2023	SELL	$6.63 - $9.9 $3,653 - $5,454	-551 Reduced 1.48%	36,803 $288,000
Q1 2023 May 18, 2023	BUY	$5.72 - $7.91 $209,117 - $289,181	36,559 Added 4598.62%	37,354 $258,000
Q1 2023 May 11, 2023	SELL	$5.72 - $7.91 $155,172 - $214,582	-27,128 Reduced 97.15%	795 $5,000
Q4 2022 Feb 13, 2023	BUY	$4.68 - $6.54 $8,634 - $12,066	1,845 Added 7.07%	27,923 $178,000
Q3 2022 Nov 14, 2022	BUY	$3.73 - $8.39 $2,099 - $4,723	563 Added 2.21%	26,078 $142,000
Q2 2022 Aug 11, 2022	BUY	$3.37 - $7.55 $85,985 - $192,638	25,515 New	25,515 $111,000

Others Institutions Holding LQDA

# of Institutions

210

Shares Held

47.5M

Call Options Held

1.61M

Put Options Held

1.15M

View Full List

About Liquidia Corp

Ticker LQDA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 64,362,300
Market Cap $1.53B
Description
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...

More about LQDA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jpmorgan Chase & CO, based on Form 13F filings with the SEC.

News

Stay updated on Jpmorgan Chase & CO with notifications on news.

Account

Jpmorgan Chase & CO Liquidia Corp Transaction History